Easom Eric 4
4 · AN2 Therapeutics, Inc. · Filed Nov 14, 2022
Insider Transaction Report
Form 4
Easom Eric
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2022-11-10$15.32/sh−4,413$67,628→ 4,930 total - Sale
Common Stock
2022-11-14$15.04/sh−23$346→ 4,907 total
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]Price reported is a weighted-average sales price. The shares were sold at prices ranging from $15.00 to $15.85. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.